The Additive Clinical Value of F-18-FDG PET/CT in Defining the Recurrence of Disease in Patients With Differentiated Thyroid Cancer Who Have Isolated Increased Antithyroglobulin Antibody Levels

---

ÖZKAN E., SOYDAL Ç., ARAZ M., Aras G., İBİŞ E.

CLINICAL NUCLEAR MEDICINE, cilt.37, sa.8, ss.755-758, 2012 (SCI-Expanded, Scopus)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 37 Sayı: 8
• Basım Tarihi: 2012
• Doi Numarası: 10.1097/rlu.0b013e31825ae77b
• Dergi Adı: CLINICAL NUCLEAR MEDICINE
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Sayfa Sayıları: ss.755-758
• Anahtar Kelimeler: differentiated thyroid cancers, antithyroglobulin antibody, F-18-FDG PET/CT, SERUM THYROGLOBULIN MEASUREMENT, FOLLOW-UP, CARCINOMA, AUTOANTIBODIES, PREVALENCE, SCAN
• Ankara Üniversitesi Adresli: Evet

Özet

Aim: The aim of this study was to investigate the additive clinical value of F-18-FDG PET/CT in defining the recurrence of disease in patients with differentiated thyroid cancer (DTC) who have isolated increased antithyroglobulin antibody (TgAb) levels with undetectable thyroglobulin (Tg) levels and negative I-131 whole-body scintigraphy (wbs).